PRL03 Pearls: Cosmetic Dermatology
DESCRIPTION
This session will deliver high-yield, rapid-fire practical pearls from expert faculty across five focused lectures: cosmetic assessment, filler, neurotoxin, energy-based devices, and hair loss. Attendees will learn to assess and categorize aesthetic concerns, refine patient evaluation, apply tailored treatment techniques, and differentiate strategies based on anatomy, product selection, and treatment modality. Emphasis will be placed on safety, efficiency, and natural outcomes, with insights grounded in real-world clinical experience.
LEARNING OBJECTIVES
Recognize key factors during the cosmetic consultation that optimize patient selection, treatment planning, and outcomes.
Differentiate evidence-based pearls for the safe and effective use of neurotoxins, fillers, energy-based devices, and hair loss treatments.
Assess anatomic, cultural, and aesthetic considerations to individualize treatment with neurotoxins, fillers, energy-based devices, and hair loss treatments.
SCHEDULE
3:15 PM
Introduction
Rohit Kakar, MD, FAAD
3:17 PM
5 Pearls for Cosmetic Assessment
Nkemjika Ugonabo, MD, FAAD
3:24 PM
5 Pearls for Neurotoxin Treatment
Daniel Aaron Belkin, MD, FAAD
3:32 PM
5 Pearls for Filler Treatment
Rohit Kakar, MD, FAAD
3:39 PM
5 Pearls for Energy-Based Devices
Michelle Fern Henry, MD
3:47 PM
5 Pearls for Hair Loss
Robert L. Finney, MD, FAAD
3:55 PM
Q&A
DIRECTOR
Rohit Kakar, MD, FAAD
SPEAKERS
Daniel Aaron Belkin, MD, FAAD
Robert L. Finney, MD, FAAD
Mount Sinai Department of Dermatology
Michelle Fern Henry, MD
Weill Cornell Medical College
Nkemjika Ugonabo, MD, FAAD
DISCLOSURES
Daniel Aaron Belkin, MD, FAAD
Alastin Skincare, Inc – Advisory Board(Fees); Allergan Aesthetics – Consultant (1099 relationship)(Honoraria); Byoma – Consultant (1099 relationship)(Fees); Merz Aesthetics – Consultant (1099 relationship)(Fees);
Robert L. Finney, MD, FAAD
No financial relationships exist with ineligible companies.
Michelle Fern Henry, MD
Aerolase – Consultant (1099 relationship)(Honoraria); Allergan – Advisory Board(Honoraria); Cynosure-Lutronic – Speaker(Honoraria); InMode – Consultant (1099 relationship)(Honoraria);
Rohit Kakar, MD, FAAD
Allergan Aesthetics – Advisory Board(Honoraria); Galderma – Consultant (1099 relationship)(Honoraria); Merz Aesthetics – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Consultant (1099 relationship)(Honoraria); Veradermics – Advisory Board(Honoraria);
Nkemjika Ugonabo, MD, FAAD
No financial relationships exist with ineligible companies.